Impulsivity and stillness: NADA, pharmaceuticals, and psychotherapy in substance use and other DSM 5 disorders

8Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention. The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses. Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component.

Cite

CITATION STYLE

APA

Carter, K., & Olshan-Perlmutter, M. (2015). Impulsivity and stillness: NADA, pharmaceuticals, and psychotherapy in substance use and other DSM 5 disorders. Behavioral Sciences, 5(4), 537–546. https://doi.org/10.3390/bs5040537

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free